REPORT ID 5200

EMEA (Europe, Middle East and Africa) Glucose Management Systems Market Report 2017

Publish Date
20-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Glucose Management Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Glucose Management Systems for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucose Management Systems market competition by top manufacturers/players, with Glucose Management Systems sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    F. Hoffmann-La Roche (Switzerland)
    Monarch Medical Technologies (US)
    Animas Corporation (US)
    LifeScan (US)
    Johnson & Johnson (US)
    DarioHealth Corp (Israel)
    Abbott (US)
    Senseonics (US)
    Dexcom (US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Data Management System
    Insulin Delivery System
    Combined System

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Home Care Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Glucose Management Systems Market Report 2017
1 Glucose Management Systems Overview
    1.1 Product Overview and Scope of Glucose Management Systems
    1.2 Classification of Glucose Management Systems
        1.2.1 EMEA Glucose Management Systems Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Glucose Management Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Data Management System
        1.2.4 Insulin Delivery System
        1.2.5 Combined System
    1.3 EMEA Glucose Management Systems Market by Application/End Users
        1.3.1 EMEA Glucose Management Systems Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home Care Settings
    1.4 EMEA Glucose Management Systems Market by Region
        1.4.1 EMEA Glucose Management Systems Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Glucose Management Systems (2012-2022)
        1.5.1 EMEA Glucose Management Systems Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Glucose Management Systems Revenue and Growth Rate (2012-2022)

2 EMEA Glucose Management Systems Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Glucose Management Systems Market Competition by Players/Manufacturers
        2.1.1 EMEA Glucose Management Systems Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Glucose Management Systems Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Glucose Management Systems Sale Price by Players (2012-2017)
    2.2 EMEA Glucose Management Systems (Volume and Value) by Type/Product Category
        2.2.1 EMEA Glucose Management Systems Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Glucose Management Systems Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Glucose Management Systems Sale Price by Type (2012-2017)
    2.3 EMEA Glucose Management Systems (Volume) by Application
    2.4 EMEA Glucose Management Systems (Volume and Value) by Region
        2.4.1 EMEA Glucose Management Systems Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Glucose Management Systems Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Glucose Management Systems Sales Price by Region (2012-2017)

3 Europe Glucose Management Systems (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Glucose Management Systems Sales and Value (2012-2017)
        3.1.1 Europe Glucose Management Systems Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Glucose Management Systems Revenue and Growth Rate (2012-2017)
    3.2 Europe Glucose Management Systems Sales and Market Share by Type
    3.3 Europe Glucose Management Systems Sales and Market Share by Application
    3.4 Europe Glucose Management Systems Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Glucose Management Systems Sales Volume by Countries (2012-2017)
        3.4.2 Europe Glucose Management Systems Revenue by Countries (2012-2017)
        3.4.3 Germany Glucose Management Systems Sales and Growth Rate (2012-2017)
        3.4.4 France Glucose Management Systems Sales and Growth Rate (2012-2017)
        3.4.5 UK Glucose Management Systems Sales and Growth Rate (2012-2017)
        3.4.6 Russia Glucose Management Systems Sales and Growth Rate (2012-2017)
        3.4.7 Italy Glucose Management Systems Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Glucose Management Systems Sales and Growth Rate (2012-2017)

4 Middle East Glucose Management Systems (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Glucose Management Systems Sales and Value (2012-2017)
        4.1.1 Middle East Glucose Management Systems Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Glucose Management Systems Revenue and Growth Rate (2012-2017)
    4.2 Middle East Glucose Management Systems Sales and Market Share by Type
    4.3 Middle East Glucose Management Systems Sales and Market Share by Application
    4.4 Middle East Glucose Management Systems Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Glucose Management Systems Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Glucose Management Systems Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Glucose Management Systems Sales and Growth Rate (2012-2017)
        4.4.4 Israel Glucose Management Systems Sales and Growth Rate (2012-2017)
        4.4.5 UAE Glucose Management Systems Sales and Growth Rate (2012-2017)
        4.4.6 Iran Glucose Management Systems Sales and Growth Rate (2012-2017)

5 Africa Glucose Management Systems (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Glucose Management Systems Sales and Value (2012-2017)
        5.1.1 Africa Glucose Management Systems Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Glucose Management Systems Revenue and Growth Rate (2012-2017)
    5.2 Africa Glucose Management Systems Sales and Market Share by Type
    5.3 Africa Glucose Management Systems Sales and Market Share by Application
    5.4 Africa Glucose Management Systems Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Glucose Management Systems Sales Volume by Countries (2012-2017)
        5.4.2 Africa Glucose Management Systems Revenue by Countries (2012-2017)
        5.4.3 South Africa Glucose Management Systems Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Glucose Management Systems Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Glucose Management Systems Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Glucose Management Systems Sales and Growth Rate (2012-2017)

6 EMEA Glucose Management Systems Manufacturers/Players Profiles and Sales Data
    6.1 F. Hoffmann-La Roche (Switzerland)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Glucose Management Systems Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 F. Hoffmann-La Roche (Switzerland) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Monarch Medical Technologies (US)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Glucose Management Systems Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Monarch Medical Technologies (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Animas Corporation (US)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Glucose Management Systems Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Animas Corporation (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 LifeScan (US)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Glucose Management Systems Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 LifeScan (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Johnson & Johnson (US)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Glucose Management Systems Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Johnson & Johnson (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 DarioHealth Corp (Israel)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Glucose Management Systems Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 DarioHealth Corp (Israel) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Abbott (US)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Glucose Management Systems Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Abbott (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Senseonics (US)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Glucose Management Systems Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Senseonics (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Dexcom (US)
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Glucose Management Systems Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Dexcom (US) Glucose Management Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Glucose Management Systems Manufacturing Cost Analysis
    7.1 Glucose Management Systems Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Glucose Management Systems

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Glucose Management Systems Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Glucose Management Systems Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Glucose Management Systems Market Forecast (2017-2022)
    11.1 EMEA Glucose Management Systems Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Glucose Management Systems Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Glucose Management Systems Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Glucose Management Systems Price and Trend Forecast (2017-2022)
    11.2 EMEA Glucose Management Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Glucose Management Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Glucose Management Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Glucose Management Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Glucose Management Systems Sales Forecast by Type (2017-2022)
    11.7 EMEA Glucose Management Systems Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer